IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<a href="https://www.smartkarma.com/entities/metlifecare-ltd" target="_blank" data-smartkarma-citation="entities:19219:1" rel="noopener">Metlifecare Ltd (MET NZ)</a> owns and operates a portfolio of 25 retirement villages and related care facilities, which are predominantly located in the upper North Island of New Zealand. Metlifecare revealed a new lower non-binding indicative offer from Asia Pacific Village Group (APVG), a unit of EQT, at NZ$6.00 cash per share under a Scheme of Arrangement. The new indicative offer is NZ$1 less (14% less) than EQT's original offer of NZ$7.00 per share.<div class="content-highlight">Recently, certain shareholders have been agitating for Metlifecare to re-engage with EQT, drop the litigation and agree on a takeover offer at a lower price, according to press reports. The Board will assess the new indicative offer and canvass the views of shareholders. On balance, we believe that the revised lower offer is reasonable and will likely get broad shareholder support. </div>

Metlifecare Ltd (MET NZ) owns and operates a portfolio of 25 retirement villages and related care facilities, which are predominantly located in the upper North Island of New Zealand. Metlifecare revealed a new lower non-binding indicative offer from Asia Pacific Village Group (APVG), a unit of EQT, at NZ$6.00 cash per share under a Scheme of Arrangement. The new indicative offer is NZ$1 less (14% less) than EQT's original offer of NZ$7.00 per share.Recently, certain shareholders have been agitating for Metlifecare to re-engage with EQT, drop the litigation and agree on a takeover offer at a lower price, according to press reports. The Board will assess the new indicative offer and canvass the views of shareholders. On balance, we believe that the revised lower offer is reasonable and will likely get broad shareholder support. 

Metlifecare Is Back in EQT’s Crosshairs

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report we take a bottoms-up view on developed ex-U.S. equities, highlighting stocks that present attractive buy opportunities within the Communications, Health Care, Manufacturing, Materials, Technology, Transportation, and Utilities Sectors

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report we take a bottoms-up view on developed ex-U.S. equities, highlighting stocks that present attractive buy opportunities within the Communications, Health Care, Manufacturing, Materials, Technology, Transportation, and Utilities Sectors

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

APAC IPOs & Placements

Zhen Zhou, Toh

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Oceania Healthcare / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/24066" target="_blank" data-smartkarma-citation="entities:24066:1">Oceania Healthcare (OCEANIA AU)</a> is looking to raise approximately US$139m in its upcoming IPO. Proceeds raised will be used to reduce debt and to provide flexibility to pursue development projects.In this insight, we will look at the company's background, projects under development, key operational data, and we will compare it with listed peers operating in New Zealand. As usual, we will also run the deal through our ECM framework.

Oceania Healthcare (OCEANIA AU) is looking to raise approximately US$139m in its upcoming IPO. Proceeds raised will be used to reduce debt and to provide flexibility to pursue development projects.In this insight, we will look at the company's background, projects under development, key operational data, and we will compare it with listed peers operating in New Zealand. As usual, we will also run the deal through our ECM framework.

Oceania Healthcare IPO Review - An Inexpensive Aged Care Facility Operator and Developer

New Zealand

Arvida Group Ltd owns and operates senior care living facilities in New Zealand.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Arvida (ARV NZ)

Metlifecare Is Back in EQT’s Crosshairs

Metlifecare Ltd (MET NZ) owns and operates a portfolio of 25 retirement villages and related care facilities, which are predominantly located in...

Arun George

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index. In today’s report...

Vermilion Research

Oceania Healthcare IPO Review - An Inexpensive Aged Care Facility Operator and Developer

Oceania Healthcare (OCEANIA AU) is looking to raise approximately US$139m in its upcoming IPO. Proceeds raised will be used to reduce debt and to...

Zhen Zhou, Toh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)